Klaus Cichutek

Klaus Cichutek is President of the Paul-Ehrlich-Institut since 2009, Federal Institute for Vaccines and Biomedicines, Germany, and extra-ordinary Professor of Biochemistry at the Goethe University Frankfurt/Main. The Paul-Ehrlich-Institut is a research and science driven Medicines Agency (veterinary and human vaccines, human biomedicines) reporting to the German Federal Ministry of Health and providing regulatory services to the European Medicines Agency EMA, EDQM, WHO and others. He studied 1976 to 1984 and became a Ph.D. in biochemnistry. After these achieved the postdoctoral scientist at the Molecular Biology and Virus Laboratory, University of California in Berkeley, U.S.A. Afterward he was head of 'Molecular Biology' Research Group, Paul-Ehrlich-Institut, Langen and head of Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen. The research interest at the Paul-Ehrlich-Institut focused of Retrovirology and gene therapy. Currently he is board member of the German Working Group of Departmental Research Institutes at Loewe Centre for Cell and Gene Therapy Frankfurt/Main. From 2016 till 2019 he was member of the WHO Expert Committee on Biological Standardization.